A previous study in rodents, induced with type 2 diabetes, demonstrated a prevention of vascular remodeling by pharmacological treatment with the MR blockade eplerenone, which was associated with a reduction in vascular oxidative stress (Silva Marcondes Alves et al., 2015). Here, NR3C2 is linked to type 2 diabetes mellitus.